The antithrombin III–saving effect of reduced systemic heparinization and heparin-coated circuits
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 16 (3) , 316-320
- https://doi.org/10.1053/jcan.2002.124140
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Clinical evaluation of Duraflo® II heparin treated extracorporeal circulation circuits (2nd version) The European working group on heparin coated extracorporeal circulation circuitsEuropean Journal of Cardio-Thoracic Surgery, 1997
- Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activationEuropean Journal of Cardio-Thoracic Surgery, 1996
- Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1α in ratsThrombosis Research, 1995
- Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effectsThe Annals of Thoracic Surgery, 1995
- Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulationThe Annals of Thoracic Surgery, 1994
- Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Risk and benefit of low systemic heparinization during open heart operationsThe Annals of Thoracic Surgery, 1994
- Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977